Cite
APA Citation
Zhang, S., Cartwright, E., Mullings, S., Ferro Lopez, L., Cunningham, D., Chau, I., Starling, N., Popat, S., O'Brien, M., Bhosle, J., Minchom, A., Davidson, M., Tokaca, N., Lalondrelle, S., Pickering, L., Furness, A., Turajlic, S., Larkin, J., José, R., & Young, K. (n.d.). 87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience. Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172207143.0x00000f